Asia has the world’s highest rate of pharmaceutical sales growth, rising at an average annual rate of 15 per cent between 2007 and 2012. This is well ahead of the US and Europe, the traditional regions of focus for big pharmaceutical companies, which experienced low single-digit growth over the same period.
As in so many other areas, the Chinese market is beyond comparison. Healthcare spending has more than doubled from $156bn in 2006 to $357bn in 2011 and is estimated to reach $1tn by 2020 – about 6 per cent of the country’s GDP. Read more